本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Nuvectis Pharma, Inc.

7.48
-0.3300-4.23%
盤後7.43-0.0469-0.63%17:48 EDT
成交量:6.86萬
成交額:51.98萬
市值:1.98億
市盈率:-5.65
高:7.83
開:7.73
低:7.41
收:7.81
52周最高:11.52
52周最低:5.55
股本:2,649.17萬
流通股本:1,453.66萬
量比:0.98
換手率:0.47%
股息:- -
股息率:- -
每股收益(TTM):-1.3236
每股收益(LYR):-1.3236
淨資產收益率:-188.03%
總資產收益率:-68.50%
市淨率:10.76
市盈率(LYR):-5.65

資料載入中...

2024/08/06

重要事件披露

Form 8-K - Current report
2024/08/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/06/13

重要事件披露

Form 8-K - Current report
2024/05/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/07

重要事件披露

Form 8-K - Current report
2024/03/05

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/05

重要事件披露

Form 8-K - Current report
2024/02/28

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/06

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/01

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/01

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/31

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/11/08

重要事件披露

Form 8-K - Current report
2023/11/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/09/12

重要事件披露

Form 8-K - Current report
2023/08/17

重要事件披露

Form 8-K - Current report
2023/08/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/09

重要事件披露

Form 8-K - Current report
2023/08/09

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/07/03

重要事件披露

Form 8-K - Current report